Occudo Quantitative Strategies’s Colgate-Palmolive CL Stock Holding History

Occudo Quantitative Strategies’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,809	Closed	-$410K	–	792
2026 Q1	$410K	Buy	+4,809	New	+$429K	0.02%	529
2025 Q4	–	Sell	-32,897	Closed	-$2.63M	–	712
2025 Q3	$2.63M	Buy	32,897 +12,944	+65%	+$1.1M	0.32%	79
2025 Q2	$1.81M	Buy	+19,953	New	+$1.82M	0.2%	141
2025 Q1	–	Sell	-29,547	Closed	-$2.69M	–	683
2024 Q4	$2.69M	Sell	29,547 -27,371	-48%	-$2.61M	0.48%	42
2024 Q3	$5.91M	Buy	+56,918	New	+$5.8M	1.08%	6
2023 Q4	–	Sell	-33,629	Closed	-$2.39M	–	836
2023 Q3	$2.39M	Buy	+33,629	New	+$2.51M	0.31%	64
2023 Q2	–	Sell	-99,037	Closed	-$7.44M	–	1049
2023 Q1	$7.44M	Buy	+99,037	New	+$7.36M	0.67%	12
2022 Q4	–	Sell	-32,954	Closed	-$2.31M	–	1021
2022 Q3	$2.31M	Buy	+32,954	New	+$2.58M	0.18%	154
2022 Q2	–	Sell	-24,047	Closed	-$1.82M	–	1162
2022 Q1	$1.82M	Buy	24,047 +13,260	+123%	+$1.05M	0.15%	199
2021 Q4	$921K	Sell	10,787 -5,138	-32%	-$401K	0.08%	390
2021 Q3	$1.2M	Buy	+15,925	New	+$1.26M	0.14%	212

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Occudo Quantitative Strategies's CL Position: Q2 2026 in Review

Occudo Quantitative Strategies sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 4,809 shares — an estimated $410K sold.

Occudo Quantitative Strategies first reported a position in CL in Q3 2021 and held it in 11 quarters. The position peaked at $7.44M in Q1 2023. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Occudo Quantitative Strategies reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
Occudo Quantitative Strategies sold 4,809 Colgate-Palmolive shares in Q2 2026, an estimated $410K.
Occudo Quantitative Strategies first reported a position in Colgate-Palmolive in Q3 2021 and held it in 11 quarters.
Occudo Quantitative Strategies's Colgate-Palmolive position peaked at $7.44M in Q1 2023.
2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.